In our study, we found that the administration of an IGF1R inhibitor reversed the microglial Rack1 deficiency‐induced protective effect of IGF1 in AD model mice, likely by inhibiting astrocyte proliferation and astrocyte‐mediated phagocytosis. Here, IGF1R is linked to Alzheimer disease.